INC Research

Shabbir Rangwala, M. has been named executive director, Global Services and site head for INC Research. Also, Sunil Garg M. has been named senior manager of Clinical Operations to help manage India-based clinical trials. They join Bhawana Awasthy, M.D., who was recently appointed senior medical director, Medical Affairs.

“India has continued to be a key region for our customers’ overall drug development strategies. We have been building the right team with the right set of clinical trials services to meet the specific needs in the country,” said Kelvin Logan, Ph.D., president INC Research Europe and Asia Pacific. “Shabbir and Sunil have proven expertise in CRO and other key clinical research settings to enable them to help guide the clinical trials outsourcing process. We are proud to welcome them to our team.”

Mr. Rangwala has 13 years of drug development experience in both CROs and pharmaceutical companies. Prior to joining the company, he held positions at Lilly, GVK Bio and iGATE Clinical Research. His responsibilities have included roles in training, quality, business operations, business development, line management and project management across India, Australia and Hong Kong.

Mr. Garg has extensive experience in establishing and managing the operations of leading CROs in India. During his career, he has worked as a part of global cross-functional teams, responsible for clinical operations, business planning and execution, project management and customer relationship management. Prior to joining INC Research, he led the clinical monitoring group for a large CRO, where he successfully managed all aspects of clinical research operations for Phase I through IV studies across multiple therapeutic areas.